Researchers have developed a rapid screening method to identify beneficial pairs of existing FDA-approved drugs to combat multi-drug resistant bacterial infections, according to a study in PLoS Biology. Read more and access the study.
Researchers have developed a rapid screening method to identify beneficial pairs of existing FDA-approved drugs to combat multi-drug resistant bacterial infections, according to a study in PLoS Biology. Read more and access the study.